# Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

> **NCT03673462** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 2797 (actual)

## Conditions studied

- Healthy Volunteers (Meningococcal Infection)

## Interventions

- **BIOLOGICAL:** Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)
- **BIOLOGICAL:** Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®)
- **BIOLOGICAL:** Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine
- **BIOLOGICAL:** Pneumococcal 13-valent Conjugate Vaccine
- **BIOLOGICAL:** Rotavirus Vaccine
- **BIOLOGICAL:** Hepatitis B Vaccine
- **BIOLOGICAL:** Measles, Mumps, and Rubella Virus Vaccine
- **BIOLOGICAL:** Varicella Virus Vaccine

## Key facts

- **NCT ID:** NCT03673462
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 2797 (ACTUAL)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03673462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03673462, "Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03673462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*